Analog Devices (NASDAQ: ADI) CAO reports option exercises and share sale
Rhea-AI Filing Summary
Analog Devices' chief accounting officer reported stock option exercises and a share sale dated 12/10/2025. The officer exercised non-qualified stock options to acquire 2,200 shares at $83.48, 1,992 shares at $91.13, and 3,977 shares at $108.08 of common stock.
The officer then sold 8,169 shares of common stock at a weighted average price of $278.0309 per share, with individual sale prices ranging from $279.437 to $249.615. After these transactions, the officer beneficially owns 18,912.691 shares of Analog Devices common stock directly.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Analog Devices (ADI) disclose in this Form 4?
The filing reports that Analog Devices' chief accounting officer exercised non-qualified stock options and sold common stock on 12/10/2025, updating the officer’s direct holdings.
How many Analog Devices (ADI) shares did the officer sell on 12/10/2025?
The officer sold 8,169 shares of Analog Devices common stock in transactions on 12/10/2025.
At what prices were the Analog Devices (ADI) stock options exercised?
The officer exercised non-qualified stock options to buy Analog Devices common stock at exercise prices of $83.48, $91.13, and $108.08 per share.
What was the weighted average sale price and range for the Analog Devices (ADI) shares sold?
The weighted average sale price for the 8,169 shares sold was $278.0309 per share, with actual sale prices ranging from $279.437 to $249.615 per share.
How many Analog Devices (ADI) shares does the officer own after these transactions?
Following the reported transactions, the officer beneficially owns 18,912.691 shares of Analog Devices common stock directly.
Were the Analog Devices (ADI) stock options fully vested when exercised?
Yes. A footnote states that each reported non-qualified stock option was fully vested at the time of exercise.
What happened to the stock options after exercise in this Analog Devices (ADI) Form 4?
After exercising the options for 2,200, 1,992, and 3,977 underlying shares, the remaining number of those derivative securities reported is 0 for each grant.